Comparative effectiveness of initial surgery vs initial systemic therapy for metastatic kidney cancer in the targeted therapy era: Analysis of a population-based cohort
Urology Nov 30, 2017
Macleod LC, et al. - The overall survival of metastatic renal cell carcinoma (mRCC) patients managed with initial cytoreductive nephrectomy (CN) was compared with initial systemic therapy. It was shown that initial CN correlated with improved survival compared with initial systemic therapy in a contemporary population-based mRCC cohort.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
